nodes	percent_of_prediction	percent_of_DWPC	metapath
Fulvestrant—CYP3A4—Salbutamol—chronic obstructive pulmonary disease	0.0919	0.282	CbGbCtD
Fulvestrant—CYP3A4—Tiotropium—chronic obstructive pulmonary disease	0.062	0.19	CbGbCtD
Fulvestrant—CYP3A4—Aminophylline—chronic obstructive pulmonary disease	0.0592	0.182	CbGbCtD
Fulvestrant—CYP3A4—Montelukast—chronic obstructive pulmonary disease	0.0528	0.162	CbGbCtD
Fulvestrant—CYP3A4—Prednisolone—chronic obstructive pulmonary disease	0.031	0.0949	CbGbCtD
Fulvestrant—CYP3A4—Prednisone—chronic obstructive pulmonary disease	0.0292	0.0897	CbGbCtD
Fulvestrant—NR1H4—connective tissue—chronic obstructive pulmonary disease	0.00841	0.142	CbGeAlD
Fulvestrant—ESRRA—respiratory system—chronic obstructive pulmonary disease	0.00732	0.123	CbGeAlD
Fulvestrant—ESRRA—bronchus—chronic obstructive pulmonary disease	0.00602	0.102	CbGeAlD
Fulvestrant—ESRRA—trachea—chronic obstructive pulmonary disease	0.00541	0.0912	CbGeAlD
Fulvestrant—EPHX2—lung—chronic obstructive pulmonary disease	0.00443	0.0748	CbGeAlD
Fulvestrant—ESR2—respiratory system—chronic obstructive pulmonary disease	0.00439	0.0741	CbGeAlD
Fulvestrant—ESRRA—lung—chronic obstructive pulmonary disease	0.00388	0.0655	CbGeAlD
Fulvestrant—ESR2—connective tissue—chronic obstructive pulmonary disease	0.00386	0.0652	CbGeAlD
Fulvestrant—NR1H4—Nuclear Receptors in Lipid Metabolism and Toxicity—CYP1A2—chronic obstructive pulmonary disease	0.00361	0.0166	CbGpPWpGaD
Fulvestrant—CYP3A4—Benzo(a)pyrene metabolism—EPHX1—chronic obstructive pulmonary disease	0.0036	0.0166	CbGpPWpGaD
Fulvestrant—ESR2—smooth muscle tissue—chronic obstructive pulmonary disease	0.00354	0.0596	CbGeAlD
Fulvestrant—ESR1—Estrogen Receptor Pathway—CYP1A2—chronic obstructive pulmonary disease	0.00342	0.0157	CbGpPWpGaD
Fulvestrant—EPHX2—Arachidonic acid metabolism—CYP1A1—chronic obstructive pulmonary disease	0.0033	0.0152	CbGpPWpGaD
Fulvestrant—NR1H4—Recycling of bile acids and salts—ALB—chronic obstructive pulmonary disease	0.00326	0.015	CbGpPWpGaD
Fulvestrant—ESR1—FOXA1 transcription factor network—SFTPD—chronic obstructive pulmonary disease	0.0031	0.0143	CbGpPWpGaD
Fulvestrant—ESR1—respiratory system—chronic obstructive pulmonary disease	0.00301	0.0507	CbGeAlD
Fulvestrant—ESR1—connective tissue—chronic obstructive pulmonary disease	0.00265	0.0447	CbGeAlD
Fulvestrant—ESR1—Estrogen Receptor Pathway—CYP1A1—chronic obstructive pulmonary disease	0.00248	0.0114	CbGpPWpGaD
Fulvestrant—ESR1—smooth muscle tissue—chronic obstructive pulmonary disease	0.00242	0.0408	CbGeAlD
Fulvestrant—ESR2—lung—chronic obstructive pulmonary disease	0.00233	0.0393	CbGeAlD
Fulvestrant—NR1H4—Cytochrome P450 - arranged by substrate type—CYP1A2—chronic obstructive pulmonary disease	0.00229	0.0106	CbGpPWpGaD
Fulvestrant—ESRRA—PPARA activates gene expression—CTGF—chronic obstructive pulmonary disease	0.00209	0.00965	CbGpPWpGaD
Fulvestrant—ESRRA—Regulation of lipid metabolism by Peroxisome proliferator-activated receptor alpha (PPARalpha)—CTGF—chronic obstructive pulmonary disease	0.00205	0.00944	CbGpPWpGaD
Fulvestrant—Estradiol—CYP1A1—chronic obstructive pulmonary disease	0.002	0.397	CrCbGaD
Fulvestrant—Estradiol—CYP1A2—chronic obstructive pulmonary disease	0.00193	0.382	CrCbGaD
Fulvestrant—NR1H4—Phase 1 - Functionalization of compounds—CYP1A2—chronic obstructive pulmonary disease	0.00186	0.00855	CbGpPWpGaD
Fulvestrant—CYP3A4—Aflatoxin B1 metabolism—CYP1A2—chronic obstructive pulmonary disease	0.00183	0.00842	CbGpPWpGaD
Fulvestrant—ESR2—Integrated Pancreatic Cancer Pathway—RAPGEF3—chronic obstructive pulmonary disease	0.00179	0.00824	CbGpPWpGaD
Fulvestrant—NR1H4—Bile acid and bile salt metabolism—ALB—chronic obstructive pulmonary disease	0.0017	0.00784	CbGpPWpGaD
Fulvestrant—ESR1—FOXA1 transcription factor network—SERPINA1—chronic obstructive pulmonary disease	0.00168	0.00772	CbGpPWpGaD
Fulvestrant—EPHX2—Metapathway biotransformation—CYP1A2—chronic obstructive pulmonary disease	0.00167	0.00767	CbGpPWpGaD
Fulvestrant—NR1H4—Cytochrome P450 - arranged by substrate type—CYP1A1—chronic obstructive pulmonary disease	0.00166	0.00767	CbGpPWpGaD
Fulvestrant—ESR1—lung—chronic obstructive pulmonary disease	0.0016	0.0269	CbGeAlD
Fulvestrant—NR1H4—PPARA activates gene expression—CTGF—chronic obstructive pulmonary disease	0.00153	0.00705	CbGpPWpGaD
Fulvestrant—NR1H4—Transmembrane transport of small molecules—ATP2C2—chronic obstructive pulmonary disease	0.00151	0.00696	CbGpPWpGaD
Fulvestrant—NR1H4—Regulation of lipid metabolism by Peroxisome proliferator-activated receptor alpha (PPARalpha)—CTGF—chronic obstructive pulmonary disease	0.0015	0.0069	CbGpPWpGaD
Fulvestrant—ESR1—Aryl Hydrocarbon Receptor—GCLC—chronic obstructive pulmonary disease	0.00148	0.00682	CbGpPWpGaD
Fulvestrant—EPHX2—Metabolism of lipids and lipoproteins—GC—chronic obstructive pulmonary disease	0.00143	0.00658	CbGpPWpGaD
Fulvestrant—ESRRA—Fatty acid, triacylglycerol, and ketone body metabolism—CTGF—chronic obstructive pulmonary disease	0.00141	0.00651	CbGpPWpGaD
Fulvestrant—ESRRA—PPARA activates gene expression—CYP1A1—chronic obstructive pulmonary disease	0.0014	0.00646	CbGpPWpGaD
Fulvestrant—CYP3A4—Aflatoxin B1 metabolism—GSTM1—chronic obstructive pulmonary disease	0.0014	0.00646	CbGpPWpGaD
Fulvestrant—NR1H4—RXR and RAR heterodimerization with other nuclear receptor—TGFB1—chronic obstructive pulmonary disease	0.0014	0.00643	CbGpPWpGaD
Fulvestrant—EPHX2—Metapathway biotransformation—GSTP1—chronic obstructive pulmonary disease	0.00139	0.0064	CbGpPWpGaD
Fulvestrant—ESRRA—Regulation of lipid metabolism by Peroxisome proliferator-activated receptor alpha (PPARalpha)—CYP1A1—chronic obstructive pulmonary disease	0.00137	0.00632	CbGpPWpGaD
Fulvestrant—NR1H4—Phase 1 - Functionalization of compounds—CYP1A1—chronic obstructive pulmonary disease	0.00135	0.00621	CbGpPWpGaD
Fulvestrant—NR1H4—Transmembrane transport of small molecules—TRPV4—chronic obstructive pulmonary disease	0.00135	0.0062	CbGpPWpGaD
Fulvestrant—NR1H4—RXR and RAR heterodimerization with other nuclear receptor—TNF—chronic obstructive pulmonary disease	0.0013	0.00601	CbGpPWpGaD
Fulvestrant—ESR2—Plasma membrane estrogen receptor signaling—NOS3—chronic obstructive pulmonary disease	0.00128	0.00589	CbGpPWpGaD
Fulvestrant—EPHX2—Metapathway biotransformation—GSTM1—chronic obstructive pulmonary disease	0.00128	0.00588	CbGpPWpGaD
Fulvestrant—Cough—Tiotropium—chronic obstructive pulmonary disease	0.00127	0.00325	CcSEcCtD
Fulvestrant—Pharyngitis—Salbutamol—chronic obstructive pulmonary disease	0.00127	0.00323	CcSEcCtD
Fulvestrant—Connective tissue disorder—Salbutamol—chronic obstructive pulmonary disease	0.00126	0.0032	CcSEcCtD
Fulvestrant—Infection—Aminophylline—chronic obstructive pulmonary disease	0.00126	0.0032	CcSEcCtD
Fulvestrant—Dizziness—Roflumilast—chronic obstructive pulmonary disease	0.00125	0.00319	CcSEcCtD
Fulvestrant—ESR1—Aryl Hydrocarbon Receptor—CYP1A2—chronic obstructive pulmonary disease	0.00124	0.00573	CbGpPWpGaD
Fulvestrant—Chest pain—Tiotropium—chronic obstructive pulmonary disease	0.00124	0.00317	CcSEcCtD
Fulvestrant—Myalgia—Tiotropium—chronic obstructive pulmonary disease	0.00124	0.00317	CcSEcCtD
Fulvestrant—Arthralgia—Tiotropium—chronic obstructive pulmonary disease	0.00124	0.00317	CcSEcCtD
Fulvestrant—Nervous system disorder—Aminophylline—chronic obstructive pulmonary disease	0.00124	0.00316	CcSEcCtD
Fulvestrant—Unspecified disorder of skin and subcutaneous tissue—Tiotropium—chronic obstructive pulmonary disease	0.00123	0.00315	CcSEcCtD
Fulvestrant—Immune system disorder—Formoterol—chronic obstructive pulmonary disease	0.00122	0.00312	CcSEcCtD
Fulvestrant—Immune system disorder—Arformoterol—chronic obstructive pulmonary disease	0.00122	0.00312	CcSEcCtD
Fulvestrant—EPHX2—Metapathway biotransformation—CYP1A1—chronic obstructive pulmonary disease	0.00121	0.00557	CbGpPWpGaD
Fulvestrant—Vomiting—Roflumilast—chronic obstructive pulmonary disease	0.00121	0.00307	CcSEcCtD
Fulvestrant—Anorexia—Aminophylline—chronic obstructive pulmonary disease	0.0012	0.00307	CcSEcCtD
Fulvestrant—Immune system disorder—Montelukast—chronic obstructive pulmonary disease	0.0012	0.00305	CcSEcCtD
Fulvestrant—Rash—Roflumilast—chronic obstructive pulmonary disease	0.0012	0.00304	CcSEcCtD
Fulvestrant—Dermatitis—Roflumilast—chronic obstructive pulmonary disease	0.00119	0.00304	CcSEcCtD
Fulvestrant—Headache—Roflumilast—chronic obstructive pulmonary disease	0.00119	0.00303	CcSEcCtD
Fulvestrant—NR1H4—Biological oxidations—GSTT1—chronic obstructive pulmonary disease	0.00119	0.00547	CbGpPWpGaD
Fulvestrant—Infection—Tiotropium—chronic obstructive pulmonary disease	0.00118	0.00302	CcSEcCtD
Fulvestrant—Malnutrition—Arformoterol—chronic obstructive pulmonary disease	0.00118	0.003	CcSEcCtD
Fulvestrant—Malnutrition—Formoterol—chronic obstructive pulmonary disease	0.00118	0.003	CcSEcCtD
Fulvestrant—NR1H4—Biological oxidations—GCLC—chronic obstructive pulmonary disease	0.00117	0.0054	CbGpPWpGaD
Fulvestrant—Nervous system disorder—Tiotropium—chronic obstructive pulmonary disease	0.00117	0.00298	CcSEcCtD
Fulvestrant—Angiopathy—Salbutamol—chronic obstructive pulmonary disease	0.00116	0.00296	CcSEcCtD
Fulvestrant—Skin disorder—Tiotropium—chronic obstructive pulmonary disease	0.00116	0.00295	CcSEcCtD
Fulvestrant—Immune system disorder—Salbutamol—chronic obstructive pulmonary disease	0.00115	0.00294	CcSEcCtD
Fulvestrant—Injury—Prednisolone—chronic obstructive pulmonary disease	0.00115	0.00294	CcSEcCtD
Fulvestrant—ESR1—ATF-2 transcription factor network—TGFB2—chronic obstructive pulmonary disease	0.00115	0.00529	CbGpPWpGaD
Fulvestrant—Insomnia—Aminophylline—chronic obstructive pulmonary disease	0.00114	0.00291	CcSEcCtD
Fulvestrant—ESRRA—Metabolism of lipids and lipoproteins—GC—chronic obstructive pulmonary disease	0.00114	0.00526	CbGpPWpGaD
Fulvestrant—Back pain—Arformoterol—chronic obstructive pulmonary disease	0.00114	0.0029	CcSEcCtD
Fulvestrant—Back pain—Formoterol—chronic obstructive pulmonary disease	0.00114	0.0029	CcSEcCtD
Fulvestrant—ESR2—SIDS Susceptibility Pathways—IL13—chronic obstructive pulmonary disease	0.00114	0.00524	CbGpPWpGaD
Fulvestrant—Nausea—Roflumilast—chronic obstructive pulmonary disease	0.00113	0.00287	CcSEcCtD
Fulvestrant—Estradiol—ALB—chronic obstructive pulmonary disease	0.00111	0.221	CrCbGaD
Fulvestrant—Malnutrition—Salbutamol—chronic obstructive pulmonary disease	0.00111	0.00284	CcSEcCtD
Fulvestrant—Dyspepsia—Aminophylline—chronic obstructive pulmonary disease	0.00111	0.00283	CcSEcCtD
Fulvestrant—Decreased appetite—Aminophylline—chronic obstructive pulmonary disease	0.0011	0.0028	CcSEcCtD
Fulvestrant—CYP3A4—Benzo(a)pyrene metabolism—CYP1A1—chronic obstructive pulmonary disease	0.00109	0.00501	CbGpPWpGaD
Fulvestrant—Musculoskeletal discomfort—Tiotropium—chronic obstructive pulmonary disease	0.00109	0.00277	CcSEcCtD
Fulvestrant—Insomnia—Tiotropium—chronic obstructive pulmonary disease	0.00108	0.00275	CcSEcCtD
Fulvestrant—Angioedema—Arformoterol—chronic obstructive pulmonary disease	0.00108	0.00274	CcSEcCtD
Fulvestrant—Angioedema—Formoterol—chronic obstructive pulmonary disease	0.00108	0.00274	CcSEcCtD
Fulvestrant—Back pain—Salbutamol—chronic obstructive pulmonary disease	0.00108	0.00274	CcSEcCtD
Fulvestrant—Paraesthesia—Tiotropium—chronic obstructive pulmonary disease	0.00107	0.00273	CcSEcCtD
Fulvestrant—Angioedema—Montelukast—chronic obstructive pulmonary disease	0.00106	0.00269	CcSEcCtD
Fulvestrant—Dyspepsia—Tiotropium—chronic obstructive pulmonary disease	0.00105	0.00267	CcSEcCtD
Fulvestrant—Gastrointestinal pain—Aminophylline—chronic obstructive pulmonary disease	0.00103	0.00263	CcSEcCtD
Fulvestrant—NR1H4—Fatty acid, triacylglycerol, and ketone body metabolism—CTGF—chronic obstructive pulmonary disease	0.00103	0.00475	CbGpPWpGaD
Fulvestrant—Gastrointestinal disorder—Tiotropium—chronic obstructive pulmonary disease	0.00103	0.00262	CcSEcCtD
Fulvestrant—Cough—Formoterol—chronic obstructive pulmonary disease	0.00103	0.00262	CcSEcCtD
Fulvestrant—Cough—Arformoterol—chronic obstructive pulmonary disease	0.00103	0.00262	CcSEcCtD
Fulvestrant—ESR2—SIDS Susceptibility Pathways—SLC6A4—chronic obstructive pulmonary disease	0.00103	0.00473	CbGpPWpGaD
Fulvestrant—ESR2—Plasma membrane estrogen receptor signaling—MMP9—chronic obstructive pulmonary disease	0.00103	0.00472	CbGpPWpGaD
Fulvestrant—NR1H4—PPARA activates gene expression—CYP1A1—chronic obstructive pulmonary disease	0.00102	0.00472	CbGpPWpGaD
Fulvestrant—Constipation—Tiotropium—chronic obstructive pulmonary disease	0.00102	0.0026	CcSEcCtD
Fulvestrant—Angioedema—Salbutamol—chronic obstructive pulmonary disease	0.00102	0.00259	CcSEcCtD
Fulvestrant—Cough—Montelukast—chronic obstructive pulmonary disease	0.00101	0.00257	CcSEcCtD
Fulvestrant—Urticaria—Aminophylline—chronic obstructive pulmonary disease	0.001	0.00256	CcSEcCtD
Fulvestrant—Myalgia—Formoterol—chronic obstructive pulmonary disease	0.001	0.00256	CcSEcCtD
Fulvestrant—Chest pain—Formoterol—chronic obstructive pulmonary disease	0.001	0.00256	CcSEcCtD
Fulvestrant—Arthralgia—Formoterol—chronic obstructive pulmonary disease	0.001	0.00256	CcSEcCtD
Fulvestrant—Arthralgia—Arformoterol—chronic obstructive pulmonary disease	0.001	0.00256	CcSEcCtD
Fulvestrant—Chest pain—Arformoterol—chronic obstructive pulmonary disease	0.001	0.00256	CcSEcCtD
Fulvestrant—Myalgia—Arformoterol—chronic obstructive pulmonary disease	0.001	0.00256	CcSEcCtD
Fulvestrant—NR1H4—Regulation of lipid metabolism by Peroxisome proliferator-activated receptor alpha (PPARalpha)—CYP1A1—chronic obstructive pulmonary disease	0.001	0.00462	CbGpPWpGaD
Fulvestrant—Anxiety—Arformoterol—chronic obstructive pulmonary disease	0.001	0.00255	CcSEcCtD
Fulvestrant—Anxiety—Formoterol—chronic obstructive pulmonary disease	0.001	0.00255	CcSEcCtD
Fulvestrant—Vertigo—Salbutamol—chronic obstructive pulmonary disease	0.001	0.00255	CcSEcCtD
Fulvestrant—Abdominal pain—Aminophylline—chronic obstructive pulmonary disease	0.000999	0.00255	CcSEcCtD
Fulvestrant—Body temperature increased—Aminophylline—chronic obstructive pulmonary disease	0.000999	0.00255	CcSEcCtD
Fulvestrant—Unspecified disorder of skin and subcutaneous tissue—Formoterol—chronic obstructive pulmonary disease	0.000997	0.00254	CcSEcCtD
Fulvestrant—Unspecified disorder of skin and subcutaneous tissue—Arformoterol—chronic obstructive pulmonary disease	0.000997	0.00254	CcSEcCtD
Fulvestrant—EPHX2—Metabolism—APIP—chronic obstructive pulmonary disease	0.000987	0.00455	CbGpPWpGaD
Fulvestrant—NR1H4—Biological oxidations—CYP1A2—chronic obstructive pulmonary disease	0.000986	0.00454	CbGpPWpGaD
Fulvestrant—Arthralgia—Montelukast—chronic obstructive pulmonary disease	0.000983	0.0025	CcSEcCtD
Fulvestrant—Myalgia—Montelukast—chronic obstructive pulmonary disease	0.000983	0.0025	CcSEcCtD
Fulvestrant—Anxiety—Montelukast—chronic obstructive pulmonary disease	0.00098	0.0025	CcSEcCtD
Fulvestrant—Unspecified disorder of skin and subcutaneous tissue—Montelukast—chronic obstructive pulmonary disease	0.000976	0.00249	CcSEcCtD
Fulvestrant—Gastrointestinal pain—Tiotropium—chronic obstructive pulmonary disease	0.000975	0.00248	CcSEcCtD
Fulvestrant—Cough—Salbutamol—chronic obstructive pulmonary disease	0.000971	0.00247	CcSEcCtD
Fulvestrant—Infection—Arformoterol—chronic obstructive pulmonary disease	0.000956	0.00243	CcSEcCtD
Fulvestrant—Infection—Formoterol—chronic obstructive pulmonary disease	0.000956	0.00243	CcSEcCtD
Fulvestrant—Chest pain—Salbutamol—chronic obstructive pulmonary disease	0.000948	0.00241	CcSEcCtD
Fulvestrant—Myalgia—Salbutamol—chronic obstructive pulmonary disease	0.000948	0.00241	CcSEcCtD
Fulvestrant—Arthralgia—Salbutamol—chronic obstructive pulmonary disease	0.000948	0.00241	CcSEcCtD
Fulvestrant—Urticaria—Tiotropium—chronic obstructive pulmonary disease	0.000947	0.00241	CcSEcCtD
Fulvestrant—ESRRA—Fatty acid, triacylglycerol, and ketone body metabolism—CYP1A1—chronic obstructive pulmonary disease	0.000946	0.00436	CbGpPWpGaD
Fulvestrant—Anxiety—Salbutamol—chronic obstructive pulmonary disease	0.000944	0.00241	CcSEcCtD
Fulvestrant—CYP3A4—Fatty Acid Omega Oxidation—CYP1A2—chronic obstructive pulmonary disease	0.000944	0.00435	CbGpPWpGaD
Fulvestrant—Nervous system disorder—Arformoterol—chronic obstructive pulmonary disease	0.000943	0.0024	CcSEcCtD
Fulvestrant—Nervous system disorder—Formoterol—chronic obstructive pulmonary disease	0.000943	0.0024	CcSEcCtD
Fulvestrant—Abdominal pain—Tiotropium—chronic obstructive pulmonary disease	0.000942	0.0024	CcSEcCtD
Fulvestrant—Infection—Montelukast—chronic obstructive pulmonary disease	0.000936	0.00239	CcSEcCtD
Fulvestrant—Skin disorder—Arformoterol—chronic obstructive pulmonary disease	0.000934	0.00238	CcSEcCtD
Fulvestrant—Skin disorder—Formoterol—chronic obstructive pulmonary disease	0.000934	0.00238	CcSEcCtD
Fulvestrant—Hypersensitivity—Aminophylline—chronic obstructive pulmonary disease	0.000931	0.00237	CcSEcCtD
Fulvestrant—Nervous system disorder—Montelukast—chronic obstructive pulmonary disease	0.000924	0.00235	CcSEcCtD
Fulvestrant—ESR1—Regulation of Telomerase—HDAC2—chronic obstructive pulmonary disease	0.00092	0.00424	CbGpPWpGaD
Fulvestrant—Skin disorder—Montelukast—chronic obstructive pulmonary disease	0.000915	0.00233	CcSEcCtD
Fulvestrant—ESR1—Signaling mediated by p38-alpha and p38-beta—NOS2—chronic obstructive pulmonary disease	0.00091	0.00419	CbGpPWpGaD
Fulvestrant—ESR1—Aryl Hydrocarbon Receptor—CYP1A1—chronic obstructive pulmonary disease	0.000904	0.00416	CbGpPWpGaD
Fulvestrant—Infection—Salbutamol—chronic obstructive pulmonary disease	0.000902	0.0023	CcSEcCtD
Fulvestrant—ESR1—Integrated Pancreatic Cancer Pathway—RAPGEF3—chronic obstructive pulmonary disease	0.000902	0.00415	CbGpPWpGaD
Fulvestrant—Pruritus—Aminophylline—chronic obstructive pulmonary disease	0.000894	0.00228	CcSEcCtD
Fulvestrant—Nervous system disorder—Salbutamol—chronic obstructive pulmonary disease	0.000891	0.00227	CcSEcCtD
Fulvestrant—Skin disorder—Salbutamol—chronic obstructive pulmonary disease	0.000882	0.00225	CcSEcCtD
Fulvestrant—Hypersensitivity—Tiotropium—chronic obstructive pulmonary disease	0.000878	0.00224	CcSEcCtD
Fulvestrant—Hyperhidrosis—Salbutamol—chronic obstructive pulmonary disease	0.000878	0.00224	CcSEcCtD
Fulvestrant—Musculoskeletal discomfort—Formoterol—chronic obstructive pulmonary disease	0.000877	0.00223	CcSEcCtD
Fulvestrant—Musculoskeletal discomfort—Arformoterol—chronic obstructive pulmonary disease	0.000877	0.00223	CcSEcCtD
Fulvestrant—Insomnia—Arformoterol—chronic obstructive pulmonary disease	0.00087	0.00222	CcSEcCtD
Fulvestrant—Insomnia—Formoterol—chronic obstructive pulmonary disease	0.00087	0.00222	CcSEcCtD
Fulvestrant—Anorexia—Salbutamol—chronic obstructive pulmonary disease	0.000866	0.00221	CcSEcCtD
Fulvestrant—Diarrhoea—Aminophylline—chronic obstructive pulmonary disease	0.000865	0.0022	CcSEcCtD
Fulvestrant—CYP3A4—Estrogen metabolism—CYP1A2—chronic obstructive pulmonary disease	0.000859	0.00396	CbGpPWpGaD
Fulvestrant—Musculoskeletal discomfort—Montelukast—chronic obstructive pulmonary disease	0.000859	0.00219	CcSEcCtD
Fulvestrant—Dyspnoea—Arformoterol—chronic obstructive pulmonary disease	0.000858	0.00219	CcSEcCtD
Fulvestrant—Dyspnoea—Formoterol—chronic obstructive pulmonary disease	0.000858	0.00219	CcSEcCtD
Fulvestrant—Insomnia—Montelukast—chronic obstructive pulmonary disease	0.000852	0.00217	CcSEcCtD
Fulvestrant—Dyspepsia—Arformoterol—chronic obstructive pulmonary disease	0.000847	0.00216	CcSEcCtD
Fulvestrant—Dyspepsia—Formoterol—chronic obstructive pulmonary disease	0.000847	0.00216	CcSEcCtD
Fulvestrant—Paraesthesia—Montelukast—chronic obstructive pulmonary disease	0.000846	0.00216	CcSEcCtD
Fulvestrant—Pruritus—Tiotropium—chronic obstructive pulmonary disease	0.000843	0.00215	CcSEcCtD
Fulvestrant—Injury—Prednisone—chronic obstructive pulmonary disease	0.000838	0.00214	CcSEcCtD
Fulvestrant—Dizziness—Aminophylline—chronic obstructive pulmonary disease	0.000836	0.00213	CcSEcCtD
Fulvestrant—NR1H4—Metabolism of lipids and lipoproteins—GC—chronic obstructive pulmonary disease	0.000834	0.00384	CbGpPWpGaD
Fulvestrant—Gastrointestinal disorder—Arformoterol—chronic obstructive pulmonary disease	0.000831	0.00212	CcSEcCtD
Fulvestrant—Gastrointestinal disorder—Formoterol—chronic obstructive pulmonary disease	0.000831	0.00212	CcSEcCtD
Fulvestrant—Dyspepsia—Montelukast—chronic obstructive pulmonary disease	0.000829	0.00211	CcSEcCtD
Fulvestrant—Fatigue—Arformoterol—chronic obstructive pulmonary disease	0.000829	0.00211	CcSEcCtD
Fulvestrant—Fatigue—Formoterol—chronic obstructive pulmonary disease	0.000829	0.00211	CcSEcCtD
Fulvestrant—Musculoskeletal discomfort—Salbutamol—chronic obstructive pulmonary disease	0.000828	0.00211	CcSEcCtD
Fulvestrant—NR1H4—Biological oxidations—GSTP1—chronic obstructive pulmonary disease	0.000823	0.00379	CbGpPWpGaD
Fulvestrant—Pain—Arformoterol—chronic obstructive pulmonary disease	0.000823	0.0021	CcSEcCtD
Fulvestrant—Constipation—Formoterol—chronic obstructive pulmonary disease	0.000823	0.0021	CcSEcCtD
Fulvestrant—Constipation—Arformoterol—chronic obstructive pulmonary disease	0.000823	0.0021	CcSEcCtD
Fulvestrant—Pain—Formoterol—chronic obstructive pulmonary disease	0.000823	0.0021	CcSEcCtD
Fulvestrant—CYP3A4—Aflatoxin activation and detoxification—CYP1A2—chronic obstructive pulmonary disease	0.000823	0.00379	CbGpPWpGaD
Fulvestrant—Insomnia—Salbutamol—chronic obstructive pulmonary disease	0.000822	0.00209	CcSEcCtD
Fulvestrant—Paraesthesia—Salbutamol—chronic obstructive pulmonary disease	0.000816	0.00208	CcSEcCtD
Fulvestrant—Gastrointestinal disorder—Montelukast—chronic obstructive pulmonary disease	0.000814	0.00207	CcSEcCtD
Fulvestrant—Fatigue—Montelukast—chronic obstructive pulmonary disease	0.000812	0.00207	CcSEcCtD
Fulvestrant—Dyspnoea—Salbutamol—chronic obstructive pulmonary disease	0.00081	0.00206	CcSEcCtD
Fulvestrant—Pain—Montelukast—chronic obstructive pulmonary disease	0.000806	0.00205	CcSEcCtD
Fulvestrant—Vomiting—Aminophylline—chronic obstructive pulmonary disease	0.000804	0.00205	CcSEcCtD
Fulvestrant—ESR1—Regulation of nuclear SMAD2/3 signaling—HDAC2—chronic obstructive pulmonary disease	0.0008	0.00369	CbGpPWpGaD
Fulvestrant—Dyspepsia—Salbutamol—chronic obstructive pulmonary disease	0.0008	0.00204	CcSEcCtD
Fulvestrant—Rash—Aminophylline—chronic obstructive pulmonary disease	0.000797	0.00203	CcSEcCtD
Fulvestrant—Dermatitis—Aminophylline—chronic obstructive pulmonary disease	0.000796	0.00203	CcSEcCtD
Fulvestrant—Headache—Aminophylline—chronic obstructive pulmonary disease	0.000792	0.00202	CcSEcCtD
Fulvestrant—Decreased appetite—Salbutamol—chronic obstructive pulmonary disease	0.00079	0.00201	CcSEcCtD
Fulvestrant—CYP3A4—Xenobiotics—CYP1A2—chronic obstructive pulmonary disease	0.00079	0.00364	CbGpPWpGaD
Fulvestrant—ESRRA—Metabolism—APIP—chronic obstructive pulmonary disease	0.000789	0.00363	CbGpPWpGaD
Fulvestrant—Dizziness—Tiotropium—chronic obstructive pulmonary disease	0.000788	0.00201	CcSEcCtD
Fulvestrant—Gastrointestinal pain—Arformoterol—chronic obstructive pulmonary disease	0.000787	0.002	CcSEcCtD
Fulvestrant—Gastrointestinal pain—Formoterol—chronic obstructive pulmonary disease	0.000787	0.002	CcSEcCtD
Fulvestrant—Gastrointestinal disorder—Salbutamol—chronic obstructive pulmonary disease	0.000784	0.002	CcSEcCtD
Fulvestrant—Fatigue—Salbutamol—chronic obstructive pulmonary disease	0.000783	0.002	CcSEcCtD
Fulvestrant—Constipation—Salbutamol—chronic obstructive pulmonary disease	0.000777	0.00198	CcSEcCtD
Fulvestrant—Pain—Salbutamol—chronic obstructive pulmonary disease	0.000777	0.00198	CcSEcCtD
Fulvestrant—Gastrointestinal pain—Montelukast—chronic obstructive pulmonary disease	0.000771	0.00196	CcSEcCtD
Fulvestrant—Urticaria—Arformoterol—chronic obstructive pulmonary disease	0.000764	0.00195	CcSEcCtD
Fulvestrant—Urticaria—Formoterol—chronic obstructive pulmonary disease	0.000764	0.00195	CcSEcCtD
Fulvestrant—Abdominal pain—Arformoterol—chronic obstructive pulmonary disease	0.000761	0.00194	CcSEcCtD
Fulvestrant—Body temperature increased—Formoterol—chronic obstructive pulmonary disease	0.000761	0.00194	CcSEcCtD
Fulvestrant—Abdominal pain—Formoterol—chronic obstructive pulmonary disease	0.000761	0.00194	CcSEcCtD
Fulvestrant—Body temperature increased—Arformoterol—chronic obstructive pulmonary disease	0.000761	0.00194	CcSEcCtD
Fulvestrant—CYP3A4—Tamoxifen metabolism—CYP1A2—chronic obstructive pulmonary disease	0.000759	0.0035	CbGpPWpGaD
Fulvestrant—Vomiting—Tiotropium—chronic obstructive pulmonary disease	0.000758	0.00193	CcSEcCtD
Fulvestrant—NR1H4—Biological oxidations—GSTM1—chronic obstructive pulmonary disease	0.000756	0.00348	CbGpPWpGaD
Fulvestrant—Rash—Tiotropium—chronic obstructive pulmonary disease	0.000752	0.00191	CcSEcCtD
Fulvestrant—Dermatitis—Tiotropium—chronic obstructive pulmonary disease	0.000751	0.00191	CcSEcCtD
Fulvestrant—Nausea—Aminophylline—chronic obstructive pulmonary disease	0.000751	0.00191	CcSEcCtD
Fulvestrant—Urticaria—Montelukast—chronic obstructive pulmonary disease	0.000749	0.00191	CcSEcCtD
Fulvestrant—Headache—Tiotropium—chronic obstructive pulmonary disease	0.000747	0.0019	CcSEcCtD
Fulvestrant—Abdominal pain—Montelukast—chronic obstructive pulmonary disease	0.000745	0.0019	CcSEcCtD
Fulvestrant—Body temperature increased—Montelukast—chronic obstructive pulmonary disease	0.000745	0.0019	CcSEcCtD
Fulvestrant—Gastrointestinal pain—Salbutamol—chronic obstructive pulmonary disease	0.000743	0.00189	CcSEcCtD
Fulvestrant—Haemoglobin—Prednisolone—chronic obstructive pulmonary disease	0.000737	0.00188	CcSEcCtD
Fulvestrant—Haemorrhage—Prednisolone—chronic obstructive pulmonary disease	0.000733	0.00187	CcSEcCtD
Fulvestrant—Urticaria—Salbutamol—chronic obstructive pulmonary disease	0.000722	0.00184	CcSEcCtD
Fulvestrant—Body temperature increased—Salbutamol—chronic obstructive pulmonary disease	0.000718	0.00183	CcSEcCtD
Fulvestrant—Abdominal pain—Salbutamol—chronic obstructive pulmonary disease	0.000718	0.00183	CcSEcCtD
Fulvestrant—NR1H4—Biological oxidations—CYP1A1—chronic obstructive pulmonary disease	0.000717	0.0033	CbGpPWpGaD
Fulvestrant—ESR2—SIDS Susceptibility Pathways—IL10—chronic obstructive pulmonary disease	0.000712	0.00328	CbGpPWpGaD
Fulvestrant—Hypersensitivity—Formoterol—chronic obstructive pulmonary disease	0.000709	0.00181	CcSEcCtD
Fulvestrant—Hypersensitivity—Arformoterol—chronic obstructive pulmonary disease	0.000709	0.00181	CcSEcCtD
Fulvestrant—Nausea—Tiotropium—chronic obstructive pulmonary disease	0.000708	0.0018	CcSEcCtD
Fulvestrant—EPHX2—Metabolism of lipids and lipoproteins—CTGF—chronic obstructive pulmonary disease	0.000704	0.00324	CbGpPWpGaD
Fulvestrant—Hypersensitivity—Montelukast—chronic obstructive pulmonary disease	0.000694	0.00177	CcSEcCtD
Fulvestrant—NR1H4—Fatty acid, triacylglycerol, and ketone body metabolism—CYP1A1—chronic obstructive pulmonary disease	0.000691	0.00318	CbGpPWpGaD
Fulvestrant—Asthenia—Formoterol—chronic obstructive pulmonary disease	0.00069	0.00176	CcSEcCtD
Fulvestrant—Asthenia—Arformoterol—chronic obstructive pulmonary disease	0.00069	0.00176	CcSEcCtD
Fulvestrant—ESR1—AP-1 transcription factor network—EDN1—chronic obstructive pulmonary disease	0.000689	0.00318	CbGpPWpGaD
Fulvestrant—CYP3A4—Fatty Acid Omega Oxidation—CYP1A1—chronic obstructive pulmonary disease	0.000686	0.00316	CbGpPWpGaD
Fulvestrant—ESR1—AP-1 transcription factor network—IL10—chronic obstructive pulmonary disease	0.000682	0.00314	CbGpPWpGaD
Fulvestrant—Pruritus—Arformoterol—chronic obstructive pulmonary disease	0.000681	0.00173	CcSEcCtD
Fulvestrant—Pruritus—Formoterol—chronic obstructive pulmonary disease	0.000681	0.00173	CcSEcCtD
Fulvestrant—Asthenia—Montelukast—chronic obstructive pulmonary disease	0.000676	0.00172	CcSEcCtD
Fulvestrant—Hypersensitivity—Salbutamol—chronic obstructive pulmonary disease	0.000669	0.00171	CcSEcCtD
Fulvestrant—ESRRA—Generic Transcription Pathway—CTGF—chronic obstructive pulmonary disease	0.000669	0.00308	CbGpPWpGaD
Fulvestrant—Pruritus—Montelukast—chronic obstructive pulmonary disease	0.000667	0.0017	CcSEcCtD
Fulvestrant—CYP3A4—Estrogen metabolism—GSTM1—chronic obstructive pulmonary disease	0.000658	0.00303	CbGpPWpGaD
Fulvestrant—Diarrhoea—Formoterol—chronic obstructive pulmonary disease	0.000658	0.00168	CcSEcCtD
Fulvestrant—Diarrhoea—Arformoterol—chronic obstructive pulmonary disease	0.000658	0.00168	CcSEcCtD
Fulvestrant—EPHX2—Metabolism—RAPGEF3—chronic obstructive pulmonary disease	0.000654	0.00301	CbGpPWpGaD
Fulvestrant—ESR1—ATF-2 transcription factor network—PLAU—chronic obstructive pulmonary disease	0.000652	0.003	CbGpPWpGaD
Fulvestrant—Asthenia—Salbutamol—chronic obstructive pulmonary disease	0.000652	0.00166	CcSEcCtD
Fulvestrant—EPHX2—Metabolism of lipids and lipoproteins—CYP1A2—chronic obstructive pulmonary disease	0.000648	0.00299	CbGpPWpGaD
Fulvestrant—Diarrhoea—Montelukast—chronic obstructive pulmonary disease	0.000645	0.00164	CcSEcCtD
Fulvestrant—ESR1—Plasma membrane estrogen receptor signaling—NOS3—chronic obstructive pulmonary disease	0.000644	0.00297	CbGpPWpGaD
Fulvestrant—Pruritus—Salbutamol—chronic obstructive pulmonary disease	0.000643	0.00164	CcSEcCtD
Fulvestrant—Dizziness—Formoterol—chronic obstructive pulmonary disease	0.000636	0.00162	CcSEcCtD
Fulvestrant—Dizziness—Arformoterol—chronic obstructive pulmonary disease	0.000636	0.00162	CcSEcCtD
Fulvestrant—EPHX2—Metabolism—GC—chronic obstructive pulmonary disease	0.000636	0.00293	CbGpPWpGaD
Fulvestrant—ESR2—SIDS Susceptibility Pathways—HTR2A—chronic obstructive pulmonary disease	0.00063	0.0029	CbGpPWpGaD
Fulvestrant—CYP3A4—Estrogen metabolism—CYP1A1—chronic obstructive pulmonary disease	0.000624	0.00287	CbGpPWpGaD
Fulvestrant—Dizziness—Montelukast—chronic obstructive pulmonary disease	0.000623	0.00159	CcSEcCtD
Fulvestrant—Diarrhoea—Salbutamol—chronic obstructive pulmonary disease	0.000622	0.00158	CcSEcCtD
Fulvestrant—Vomiting—Arformoterol—chronic obstructive pulmonary disease	0.000612	0.00156	CcSEcCtD
Fulvestrant—Vomiting—Formoterol—chronic obstructive pulmonary disease	0.000612	0.00156	CcSEcCtD
Fulvestrant—Rash—Formoterol—chronic obstructive pulmonary disease	0.000607	0.00155	CcSEcCtD
Fulvestrant—Rash—Arformoterol—chronic obstructive pulmonary disease	0.000607	0.00155	CcSEcCtD
Fulvestrant—ESR1—Regulation of nuclear SMAD2/3 signaling—IL10—chronic obstructive pulmonary disease	0.000606	0.00279	CbGpPWpGaD
Fulvestrant—Dermatitis—Arformoterol—chronic obstructive pulmonary disease	0.000606	0.00154	CcSEcCtD
Fulvestrant—Dermatitis—Formoterol—chronic obstructive pulmonary disease	0.000606	0.00154	CcSEcCtD
Fulvestrant—Headache—Formoterol—chronic obstructive pulmonary disease	0.000603	0.00154	CcSEcCtD
Fulvestrant—Headache—Arformoterol—chronic obstructive pulmonary disease	0.000603	0.00154	CcSEcCtD
Fulvestrant—Dizziness—Salbutamol—chronic obstructive pulmonary disease	0.000601	0.00153	CcSEcCtD
Fulvestrant—Vomiting—Montelukast—chronic obstructive pulmonary disease	0.000599	0.00153	CcSEcCtD
Fulvestrant—ESR1—ATF-2 transcription factor network—NOS2—chronic obstructive pulmonary disease	0.000599	0.00276	CbGpPWpGaD
Fulvestrant—Rash—Montelukast—chronic obstructive pulmonary disease	0.000594	0.00151	CcSEcCtD
Fulvestrant—Dermatitis—Montelukast—chronic obstructive pulmonary disease	0.000594	0.00151	CcSEcCtD
Fulvestrant—Depression—Prednisone—chronic obstructive pulmonary disease	0.000592	0.00151	CcSEcCtD
Fulvestrant—EPHX2—Metabolism—ALDH7A1—chronic obstructive pulmonary disease	0.000591	0.00272	CbGpPWpGaD
Fulvestrant—Headache—Montelukast—chronic obstructive pulmonary disease	0.00059	0.0015	CcSEcCtD
Fulvestrant—Angioedema—Prednisolone—chronic obstructive pulmonary disease	0.000583	0.00149	CcSEcCtD
Fulvestrant—ESR1—AP-1 transcription factor network—MMP1—chronic obstructive pulmonary disease	0.000579	0.00267	CbGpPWpGaD
Fulvestrant—Vomiting—Salbutamol—chronic obstructive pulmonary disease	0.000578	0.00147	CcSEcCtD
Fulvestrant—NR1H4—Metabolism—APIP—chronic obstructive pulmonary disease	0.000577	0.00266	CbGpPWpGaD
Fulvestrant—CYP3A4—Xenobiotics—CYP1A1—chronic obstructive pulmonary disease	0.000574	0.00264	CbGpPWpGaD
Fulvestrant—Vertigo—Prednisolone—chronic obstructive pulmonary disease	0.000574	0.00146	CcSEcCtD
Fulvestrant—Rash—Salbutamol—chronic obstructive pulmonary disease	0.000573	0.00146	CcSEcCtD
Fulvestrant—Dermatitis—Salbutamol—chronic obstructive pulmonary disease	0.000572	0.00146	CcSEcCtD
Fulvestrant—Nausea—Formoterol—chronic obstructive pulmonary disease	0.000571	0.00146	CcSEcCtD
Fulvestrant—Nausea—Arformoterol—chronic obstructive pulmonary disease	0.000571	0.00146	CcSEcCtD
Fulvestrant—Headache—Salbutamol—chronic obstructive pulmonary disease	0.000569	0.00145	CcSEcCtD
Fulvestrant—ESR1—AP-1 transcription factor network—PLAU—chronic obstructive pulmonary disease	0.000569	0.00262	CbGpPWpGaD
Fulvestrant—ESRRA—Metabolism of lipids and lipoproteins—CTGF—chronic obstructive pulmonary disease	0.000563	0.00259	CbGpPWpGaD
Fulvestrant—Nausea—Montelukast—chronic obstructive pulmonary disease	0.00056	0.00143	CcSEcCtD
Fulvestrant—CYP3A4—Tamoxifen metabolism—CYP1A1—chronic obstructive pulmonary disease	0.000552	0.00254	CbGpPWpGaD
Fulvestrant—Nausea—Salbutamol—chronic obstructive pulmonary disease	0.00054	0.00137	CcSEcCtD
Fulvestrant—Haemoglobin—Prednisone—chronic obstructive pulmonary disease	0.000536	0.00136	CcSEcCtD
Fulvestrant—Haemorrhage—Prednisone—chronic obstructive pulmonary disease	0.000533	0.00136	CcSEcCtD
Fulvestrant—ESR1—Leptin signaling pathway—LEP—chronic obstructive pulmonary disease	0.000531	0.00244	CbGpPWpGaD
Fulvestrant—Connective tissue disorder—Prednisone—chronic obstructive pulmonary disease	0.000524	0.00133	CcSEcCtD
Fulvestrant—ESRRA—Metabolism—RAPGEF3—chronic obstructive pulmonary disease	0.000523	0.00241	CbGpPWpGaD
Fulvestrant—ESRRA—Metabolism of lipids and lipoproteins—CYP1A2—chronic obstructive pulmonary disease	0.000518	0.00239	CbGpPWpGaD
Fulvestrant—ESR1—Plasma membrane estrogen receptor signaling—MMP9—chronic obstructive pulmonary disease	0.000517	0.00238	CbGpPWpGaD
Fulvestrant—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—CYP1A2—chronic obstructive pulmonary disease	0.000516	0.00238	CbGpPWpGaD
Fulvestrant—ESRRA—Metabolism—GC—chronic obstructive pulmonary disease	0.000508	0.00234	CbGpPWpGaD
Fulvestrant—Hyperhidrosis—Prednisolone—chronic obstructive pulmonary disease	0.000504	0.00128	CcSEcCtD
Fulvestrant—NR1H4—Generic Transcription Pathway—CTGF—chronic obstructive pulmonary disease	0.000489	0.00225	CbGpPWpGaD
Fulvestrant—Angiopathy—Prednisone—chronic obstructive pulmonary disease	0.000484	0.00123	CcSEcCtD
Fulvestrant—Immune system disorder—Prednisone—chronic obstructive pulmonary disease	0.000481	0.00123	CcSEcCtD
Fulvestrant—ESRRA—Metabolism—ALDH7A1—chronic obstructive pulmonary disease	0.000473	0.00218	CbGpPWpGaD
Fulvestrant—Insomnia—Prednisolone—chronic obstructive pulmonary disease	0.000471	0.0012	CcSEcCtD
Fulvestrant—EPHX2—Metabolism of lipids and lipoproteins—CYP1A1—chronic obstructive pulmonary disease	0.000471	0.00217	CbGpPWpGaD
Fulvestrant—Paraesthesia—Prednisolone—chronic obstructive pulmonary disease	0.000468	0.00119	CcSEcCtD
Fulvestrant—Malnutrition—Prednisone—chronic obstructive pulmonary disease	0.000464	0.00118	CcSEcCtD
Fulvestrant—ESR1—Signaling by ERBB4—KL—chronic obstructive pulmonary disease	0.00045	0.00207	CbGpPWpGaD
Fulvestrant—Pain—Prednisolone—chronic obstructive pulmonary disease	0.000446	0.00114	CcSEcCtD
Fulvestrant—Anaemia—Prednisone—chronic obstructive pulmonary disease	0.000429	0.00109	CcSEcCtD
Fulvestrant—ESR1—ATF-2 transcription factor network—CXCL8—chronic obstructive pulmonary disease	0.000427	0.00197	CbGpPWpGaD
Fulvestrant—ESR2—Generic Transcription Pathway—CTGF—chronic obstructive pulmonary disease	0.000426	0.00196	CbGpPWpGaD
Fulvestrant—Angioedema—Prednisone—chronic obstructive pulmonary disease	0.000424	0.00108	CcSEcCtD
Fulvestrant—ESR1—Aryl Hydrocarbon Receptor—VEGFA—chronic obstructive pulmonary disease	0.000423	0.00195	CbGpPWpGaD
Fulvestrant—Vertigo—Prednisone—chronic obstructive pulmonary disease	0.000417	0.00106	CcSEcCtD
Fulvestrant—Urticaria—Prednisolone—chronic obstructive pulmonary disease	0.000414	0.00105	CcSEcCtD
Fulvestrant—NR1H4—Metabolism of lipids and lipoproteins—CTGF—chronic obstructive pulmonary disease	0.000411	0.00189	CbGpPWpGaD
Fulvestrant—CYP3A4—Tryptophan metabolism—CYP1A2—chronic obstructive pulmonary disease	0.000406	0.00187	CbGpPWpGaD
Fulvestrant—ESR1—Signaling mediated by p38-alpha and p38-beta—TP53—chronic obstructive pulmonary disease	0.000398	0.00183	CbGpPWpGaD
Fulvestrant—ESR1—Leptin signaling pathway—NOS3—chronic obstructive pulmonary disease	0.000398	0.00183	CbGpPWpGaD
Fulvestrant—Arthralgia—Prednisone—chronic obstructive pulmonary disease	0.000395	0.00101	CcSEcCtD
Fulvestrant—Myalgia—Prednisone—chronic obstructive pulmonary disease	0.000395	0.00101	CcSEcCtD
Fulvestrant—Anxiety—Prednisone—chronic obstructive pulmonary disease	0.000394	0.001	CcSEcCtD
Fulvestrant—Unspecified disorder of skin and subcutaneous tissue—Prednisone—chronic obstructive pulmonary disease	0.000392	0.000999	CcSEcCtD
Fulvestrant—ESR1—Regulation of nuclear SMAD2/3 signaling—SERPINE1—chronic obstructive pulmonary disease	0.000392	0.0018	CbGpPWpGaD
Fulvestrant—ESR2—SIDS Susceptibility Pathways—CXCL8—chronic obstructive pulmonary disease	0.000389	0.00179	CbGpPWpGaD
Fulvestrant—Hypersensitivity—Prednisolone—chronic obstructive pulmonary disease	0.000384	0.000978	CcSEcCtD
Fulvestrant—NR1H4—Metabolism—RAPGEF3—chronic obstructive pulmonary disease	0.000382	0.00176	CbGpPWpGaD
Fulvestrant—ESR1—Aryl Hydrocarbon Receptor—EGFR—chronic obstructive pulmonary disease	0.000381	0.00176	CbGpPWpGaD
Fulvestrant—NR1H4—Metabolism of lipids and lipoproteins—CYP1A2—chronic obstructive pulmonary disease	0.000379	0.00174	CbGpPWpGaD
Fulvestrant—ESRRA—Metabolism of lipids and lipoproteins—CYP1A1—chronic obstructive pulmonary disease	0.000377	0.00173	CbGpPWpGaD
Fulvestrant—Infection—Prednisone—chronic obstructive pulmonary disease	0.000376	0.000958	CcSEcCtD
Fulvestrant—ESR2—SIDS Susceptibility Pathways—IL1B—chronic obstructive pulmonary disease	0.000373	0.00172	CbGpPWpGaD
Fulvestrant—ESR1—AP-1 transcription factor network—CXCL8—chronic obstructive pulmonary disease	0.000373	0.00172	CbGpPWpGaD
Fulvestrant—NR1H4—Metabolism—GC—chronic obstructive pulmonary disease	0.000372	0.00171	CbGpPWpGaD
Fulvestrant—Nervous system disorder—Prednisone—chronic obstructive pulmonary disease	0.000371	0.000946	CcSEcCtD
Fulvestrant—Skin disorder—Prednisone—chronic obstructive pulmonary disease	0.000368	0.000937	CcSEcCtD
Fulvestrant—Hyperhidrosis—Prednisone—chronic obstructive pulmonary disease	0.000366	0.000932	CcSEcCtD
Fulvestrant—ESR1—Aryl Hydrocarbon Receptor—TNF—chronic obstructive pulmonary disease	0.000363	0.00167	CbGpPWpGaD
Fulvestrant—Anorexia—Prednisone—chronic obstructive pulmonary disease	0.000361	0.000919	CcSEcCtD
Fulvestrant—EPHX2—Metabolism—GSTT1—chronic obstructive pulmonary disease	0.000347	0.0016	CbGpPWpGaD
Fulvestrant—NR1H4—Metabolism—ALDH7A1—chronic obstructive pulmonary disease	0.000345	0.00159	CbGpPWpGaD
Fulvestrant—Musculoskeletal discomfort—Prednisone—chronic obstructive pulmonary disease	0.000345	0.000879	CcSEcCtD
Fulvestrant—Dizziness—Prednisolone—chronic obstructive pulmonary disease	0.000345	0.000878	CcSEcCtD
Fulvestrant—EPHX2—Metabolism—GCLC—chronic obstructive pulmonary disease	0.000343	0.00158	CbGpPWpGaD
Fulvestrant—Insomnia—Prednisone—chronic obstructive pulmonary disease	0.000342	0.000872	CcSEcCtD
Fulvestrant—Paraesthesia—Prednisone—chronic obstructive pulmonary disease	0.00034	0.000866	CcSEcCtD
Fulvestrant—ESR1—Leptin signaling pathway—IL1B—chronic obstructive pulmonary disease	0.000338	0.00156	CbGpPWpGaD
Fulvestrant—ESR1—LKB1 signaling events—TP53—chronic obstructive pulmonary disease	0.000338	0.00156	CbGpPWpGaD
Fulvestrant—ESR1—AP-1 transcription factor network—MMP9—chronic obstructive pulmonary disease	0.000337	0.00155	CbGpPWpGaD
Fulvestrant—ESR1—Signaling by ERBB4—ERBB3—chronic obstructive pulmonary disease	0.000337	0.00155	CbGpPWpGaD
Fulvestrant—CYP3A4—Metapathway biotransformation—EPHX1—chronic obstructive pulmonary disease	0.000335	0.00154	CbGpPWpGaD
Fulvestrant—Dyspepsia—Prednisone—chronic obstructive pulmonary disease	0.000333	0.000849	CcSEcCtD
Fulvestrant—Decreased appetite—Prednisone—chronic obstructive pulmonary disease	0.000329	0.000839	CcSEcCtD
Fulvestrant—Rash—Prednisolone—chronic obstructive pulmonary disease	0.000329	0.000837	CcSEcCtD
Fulvestrant—Dermatitis—Prednisolone—chronic obstructive pulmonary disease	0.000328	0.000836	CcSEcCtD
Fulvestrant—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP1A2—chronic obstructive pulmonary disease	0.000328	0.00151	CbGpPWpGaD
Fulvestrant—Fatigue—Prednisone—chronic obstructive pulmonary disease	0.000326	0.000832	CcSEcCtD
Fulvestrant—Headache—Prednisolone—chronic obstructive pulmonary disease	0.000326	0.000832	CcSEcCtD
Fulvestrant—Constipation—Prednisone—chronic obstructive pulmonary disease	0.000324	0.000825	CcSEcCtD
Fulvestrant—CYP3A4—Oxidation by Cytochrome P450—CYP1A2—chronic obstructive pulmonary disease	0.000324	0.00149	CbGpPWpGaD
Fulvestrant—ESRRA—Gene Expression—CTGF—chronic obstructive pulmonary disease	0.000322	0.00148	CbGpPWpGaD
Fulvestrant—EPHX2—Metabolism of lipids and lipoproteins—ALB—chronic obstructive pulmonary disease	0.00032	0.00147	CbGpPWpGaD
Fulvestrant—ESR2—SIDS Susceptibility Pathways—VEGFA—chronic obstructive pulmonary disease	0.000316	0.00146	CbGpPWpGaD
Fulvestrant—EPHX2—Metabolism—CTGF—chronic obstructive pulmonary disease	0.000313	0.00144	CbGpPWpGaD
Fulvestrant—ESR1—Integrated Breast Cancer Pathway—MMP1—chronic obstructive pulmonary disease	0.000313	0.00144	CbGpPWpGaD
Fulvestrant—Gastrointestinal pain—Prednisone—chronic obstructive pulmonary disease	0.00031	0.000789	CcSEcCtD
Fulvestrant—Nausea—Prednisolone—chronic obstructive pulmonary disease	0.000309	0.000788	CcSEcCtD
Fulvestrant—ESRRA—Generic Transcription Pathway—SERPINE1—chronic obstructive pulmonary disease	0.000305	0.00141	CbGpPWpGaD
Fulvestrant—Urticaria—Prednisone—chronic obstructive pulmonary disease	0.000301	0.000766	CcSEcCtD
Fulvestrant—ESRRA—Gene Expression—HDAC2—chronic obstructive pulmonary disease	0.0003	0.00138	CbGpPWpGaD
Fulvestrant—Abdominal pain—Prednisone—chronic obstructive pulmonary disease	0.000299	0.000763	CcSEcCtD
Fulvestrant—Body temperature increased—Prednisone—chronic obstructive pulmonary disease	0.000299	0.000763	CcSEcCtD
Fulvestrant—NR1H4—Transmembrane transport of small molecules—HMOX1—chronic obstructive pulmonary disease	0.000296	0.00136	CbGpPWpGaD
Fulvestrant—CYP3A4—Tryptophan metabolism—CYP1A1—chronic obstructive pulmonary disease	0.000295	0.00136	CbGpPWpGaD
Fulvestrant—EPHX2—Metabolism—CYP1A2—chronic obstructive pulmonary disease	0.000289	0.00133	CbGpPWpGaD
Fulvestrant—ESR1—Regulation of Telomerase—TGFB1—chronic obstructive pulmonary disease	0.000284	0.00131	CbGpPWpGaD
Fulvestrant—Hypersensitivity—Prednisone—chronic obstructive pulmonary disease	0.000279	0.000711	CcSEcCtD
Fulvestrant—ESR1—Regulation of Telomerase—EGFR—chronic obstructive pulmonary disease	0.000279	0.00128	CbGpPWpGaD
Fulvestrant—ESR1—AP-1 transcription factor network—TGFB1—chronic obstructive pulmonary disease	0.000278	0.00128	CbGpPWpGaD
Fulvestrant—ESRRA—Metabolism—GSTT1—chronic obstructive pulmonary disease	0.000278	0.00128	CbGpPWpGaD
Fulvestrant—NR1H4—Metabolism of lipids and lipoproteins—CYP1A1—chronic obstructive pulmonary disease	0.000275	0.00127	CbGpPWpGaD
Fulvestrant—ESRRA—Metabolism—GCLC—chronic obstructive pulmonary disease	0.000275	0.00126	CbGpPWpGaD
Fulvestrant—Asthenia—Prednisone—chronic obstructive pulmonary disease	0.000272	0.000692	CcSEcCtD
Fulvestrant—ESR2—SIDS Susceptibility Pathways—TNF—chronic obstructive pulmonary disease	0.000271	0.00125	CbGpPWpGaD
Fulvestrant—ESR2—Integrated Pancreatic Cancer Pathway—VEGFA—chronic obstructive pulmonary disease	0.000269	0.00124	CbGpPWpGaD
Fulvestrant—Pruritus—Prednisone—chronic obstructive pulmonary disease	0.000268	0.000682	CcSEcCtD
Fulvestrant—CYP3A4—Phase 1 - Functionalization of compounds—CYP1A2—chronic obstructive pulmonary disease	0.000266	0.00122	CbGpPWpGaD
Fulvestrant—Diarrhoea—Prednisone—chronic obstructive pulmonary disease	0.000259	0.00066	CcSEcCtD
Fulvestrant—ESRRA—Metabolism of lipids and lipoproteins—ALB—chronic obstructive pulmonary disease	0.000256	0.00118	CbGpPWpGaD
Fulvestrant—ESRRA—Metabolism—CTGF—chronic obstructive pulmonary disease	0.000251	0.00115	CbGpPWpGaD
Fulvestrant—Dizziness—Prednisone—chronic obstructive pulmonary disease	0.00025	0.000638	CcSEcCtD
Fulvestrant—ESR2—Integrated Pancreatic Cancer Pathway—TGFB1—chronic obstructive pulmonary disease	0.000247	0.00114	CbGpPWpGaD
Fulvestrant—ESR2—Integrated Pancreatic Cancer Pathway—EGFR—chronic obstructive pulmonary disease	0.000242	0.00111	CbGpPWpGaD
Fulvestrant—EPHX2—Metabolism—GSTP1—chronic obstructive pulmonary disease	0.000241	0.00111	CbGpPWpGaD
Fulvestrant—Vomiting—Prednisone—chronic obstructive pulmonary disease	0.000241	0.000613	CcSEcCtD
Fulvestrant—ESR1—ATF-2 transcription factor network—IL6—chronic obstructive pulmonary disease	0.00024	0.00111	CbGpPWpGaD
Fulvestrant—Rash—Prednisone—chronic obstructive pulmonary disease	0.000239	0.000608	CcSEcCtD
Fulvestrant—Dermatitis—Prednisone—chronic obstructive pulmonary disease	0.000239	0.000608	CcSEcCtD
Fulvestrant—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP1A1—chronic obstructive pulmonary disease	0.000238	0.0011	CbGpPWpGaD
Fulvestrant—EPHX2—Metabolism—HMOX1—chronic obstructive pulmonary disease	0.000238	0.00109	CbGpPWpGaD
Fulvestrant—Headache—Prednisone—chronic obstructive pulmonary disease	0.000237	0.000604	CcSEcCtD
Fulvestrant—NR1H4—Gene Expression—CTGF—chronic obstructive pulmonary disease	0.000235	0.00108	CbGpPWpGaD
Fulvestrant—CYP3A4—Oxidation by Cytochrome P450—CYP1A1—chronic obstructive pulmonary disease	0.000235	0.00108	CbGpPWpGaD
Fulvestrant—ESR1—Signaling Pathways—FAM13A—chronic obstructive pulmonary disease	0.000231	0.00107	CbGpPWpGaD
Fulvestrant—ESRRA—Metabolism—CYP1A2—chronic obstructive pulmonary disease	0.000231	0.00106	CbGpPWpGaD
Fulvestrant—ESR2—Integrated Pancreatic Cancer Pathway—TNF—chronic obstructive pulmonary disease	0.00023	0.00106	CbGpPWpGaD
Fulvestrant—ESR1—AP-1 transcription factor network—TP53—chronic obstructive pulmonary disease	0.000229	0.00105	CbGpPWpGaD
Fulvestrant—Nausea—Prednisone—chronic obstructive pulmonary disease	0.000225	0.000573	CcSEcCtD
Fulvestrant—NR1H4—Generic Transcription Pathway—SERPINE1—chronic obstructive pulmonary disease	0.000223	0.00103	CbGpPWpGaD
Fulvestrant—EPHX2—Metabolism—GSTM1—chronic obstructive pulmonary disease	0.000221	0.00102	CbGpPWpGaD
Fulvestrant—NR1H4—Gene Expression—HDAC2—chronic obstructive pulmonary disease	0.000219	0.00101	CbGpPWpGaD
Fulvestrant—ESR2—SIDS Susceptibility Pathways—IL6—chronic obstructive pulmonary disease	0.000219	0.00101	CbGpPWpGaD
Fulvestrant—ESR1—Generic Transcription Pathway—CTGF—chronic obstructive pulmonary disease	0.000215	0.000989	CbGpPWpGaD
Fulvestrant—EPHX2—Metabolism—CYP1A1—chronic obstructive pulmonary disease	0.00021	0.000966	CbGpPWpGaD
Fulvestrant—ESR1—AP-1 transcription factor network—IL6—chronic obstructive pulmonary disease	0.000209	0.000964	CbGpPWpGaD
Fulvestrant—ESR2—Gene Expression—CTGF—chronic obstructive pulmonary disease	0.000205	0.000944	CbGpPWpGaD
Fulvestrant—ESR2—Integrated Pancreatic Cancer Pathway—TP53—chronic obstructive pulmonary disease	0.000203	0.000936	CbGpPWpGaD
Fulvestrant—NR1H4—Metabolism—GSTT1—chronic obstructive pulmonary disease	0.000203	0.000935	CbGpPWpGaD
Fulvestrant—NR1H4—Metabolism—GCLC—chronic obstructive pulmonary disease	0.000201	0.000924	CbGpPWpGaD
Fulvestrant—ESR2—Generic Transcription Pathway—SERPINE1—chronic obstructive pulmonary disease	0.000194	0.000894	CbGpPWpGaD
Fulvestrant—CYP3A4—Phase 1 - Functionalization of compounds—CYP1A1—chronic obstructive pulmonary disease	0.000193	0.00089	CbGpPWpGaD
Fulvestrant—ESRRA—Metabolism—GSTP1—chronic obstructive pulmonary disease	0.000193	0.000887	CbGpPWpGaD
Fulvestrant—ESR2—Gene Expression—HDAC2—chronic obstructive pulmonary disease	0.000191	0.00088	CbGpPWpGaD
Fulvestrant—ESRRA—Metabolism—HMOX1—chronic obstructive pulmonary disease	0.00019	0.000875	CbGpPWpGaD
Fulvestrant—NR1H4—Metabolism of lipids and lipoproteins—ALB—chronic obstructive pulmonary disease	0.000187	0.000862	CbGpPWpGaD
Fulvestrant—NR1H4—Metabolism—CTGF—chronic obstructive pulmonary disease	0.000183	0.000843	CbGpPWpGaD
Fulvestrant—NR1H4—Transmembrane transport of small molecules—ALB—chronic obstructive pulmonary disease	0.000178	0.000819	CbGpPWpGaD
Fulvestrant—ESRRA—Metabolism—GSTM1—chronic obstructive pulmonary disease	0.000177	0.000815	CbGpPWpGaD
Fulvestrant—CYP3A4—Biological oxidations—GSTT1—chronic obstructive pulmonary disease	0.00017	0.000783	CbGpPWpGaD
Fulvestrant—NR1H4—Metabolism—CYP1A2—chronic obstructive pulmonary disease	0.000169	0.000777	CbGpPWpGaD
Fulvestrant—CYP3A4—Biological oxidations—GCLC—chronic obstructive pulmonary disease	0.000168	0.000774	CbGpPWpGaD
Fulvestrant—ESRRA—Metabolism—CYP1A1—chronic obstructive pulmonary disease	0.000168	0.000773	CbGpPWpGaD
Fulvestrant—ESR1—Integrated Breast Cancer Pathway—VEGFA—chronic obstructive pulmonary disease	0.000164	0.000754	CbGpPWpGaD
Fulvestrant—ESR1—Integrated Breast Cancer Pathway—EGFR—chronic obstructive pulmonary disease	0.000147	0.000678	CbGpPWpGaD
Fulvestrant—ESRRA—Gene Expression—SERPINE1—chronic obstructive pulmonary disease	0.000147	0.000677	CbGpPWpGaD
Fulvestrant—ESR1—Signaling by ERBB4—EGFR—chronic obstructive pulmonary disease	0.000146	0.000675	CbGpPWpGaD
Fulvestrant—EPHX2—Metabolism—ALB—chronic obstructive pulmonary disease	0.000143	0.000657	CbGpPWpGaD
Fulvestrant—CYP3A4—Biological oxidations—CYP1A2—chronic obstructive pulmonary disease	0.000141	0.00065	CbGpPWpGaD
Fulvestrant—NR1H4—Metabolism—GSTP1—chronic obstructive pulmonary disease	0.000141	0.000648	CbGpPWpGaD
Fulvestrant—ESR1—Signaling Pathways—RAPGEF3—chronic obstructive pulmonary disease	0.00014	0.000646	CbGpPWpGaD
Fulvestrant—CYP3A4—Metapathway biotransformation—CYP1A2—chronic obstructive pulmonary disease	0.000139	0.000641	CbGpPWpGaD
Fulvestrant—NR1H4—Metabolism—HMOX1—chronic obstructive pulmonary disease	0.000139	0.000639	CbGpPWpGaD
Fulvestrant—EPHX2—Metabolism—NOS3—chronic obstructive pulmonary disease	0.000136	0.000628	CbGpPWpGaD
Fulvestrant—ESR1—Integrated Pancreatic Cancer Pathway—VEGFA—chronic obstructive pulmonary disease	0.000136	0.000624	CbGpPWpGaD
Fulvestrant—NR1H4—Metabolism—GSTM1—chronic obstructive pulmonary disease	0.000129	0.000595	CbGpPWpGaD
Fulvestrant—ESR1—Integrated Pancreatic Cancer Pathway—TGFB1—chronic obstructive pulmonary disease	0.000124	0.000573	CbGpPWpGaD
Fulvestrant—ESR1—Integrated Breast Cancer Pathway—TP53—chronic obstructive pulmonary disease	0.000124	0.000569	CbGpPWpGaD
Fulvestrant—NR1H4—Metabolism—CYP1A1—chronic obstructive pulmonary disease	0.000123	0.000565	CbGpPWpGaD
Fulvestrant—ESR1—Integrated Pancreatic Cancer Pathway—EGFR—chronic obstructive pulmonary disease	0.000122	0.000562	CbGpPWpGaD
Fulvestrant—CYP3A4—Biological oxidations—GSTP1—chronic obstructive pulmonary disease	0.000118	0.000542	CbGpPWpGaD
Fulvestrant—ESR1—Integrated Pancreatic Cancer Pathway—TNF—chronic obstructive pulmonary disease	0.000116	0.000535	CbGpPWpGaD
Fulvestrant—CYP3A4—Metapathway biotransformation—GSTP1—chronic obstructive pulmonary disease	0.000116	0.000535	CbGpPWpGaD
Fulvestrant—ESRRA—Metabolism—ALB—chronic obstructive pulmonary disease	0.000114	0.000525	CbGpPWpGaD
Fulvestrant—ESR1—Signaling by ERBB4—IL6—chronic obstructive pulmonary disease	0.000113	0.000518	CbGpPWpGaD
Fulvestrant—ESRRA—Metabolism—NOS3—chronic obstructive pulmonary disease	0.000109	0.000502	CbGpPWpGaD
Fulvestrant—CYP3A4—Biological oxidations—GSTM1—chronic obstructive pulmonary disease	0.000108	0.000498	CbGpPWpGaD
Fulvestrant—NR1H4—Gene Expression—SERPINE1—chronic obstructive pulmonary disease	0.000107	0.000494	CbGpPWpGaD
Fulvestrant—CYP3A4—Metapathway biotransformation—GSTM1—chronic obstructive pulmonary disease	0.000107	0.000492	CbGpPWpGaD
Fulvestrant—ESR1—Signaling Pathways—PDE4A—chronic obstructive pulmonary disease	0.000106	0.00049	CbGpPWpGaD
Fulvestrant—ESR1—Gene Expression—CTGF—chronic obstructive pulmonary disease	0.000103	0.000476	CbGpPWpGaD
Fulvestrant—CYP3A4—Biological oxidations—CYP1A1—chronic obstructive pulmonary disease	0.000103	0.000473	CbGpPWpGaD
Fulvestrant—ESR1—Integrated Pancreatic Cancer Pathway—TP53—chronic obstructive pulmonary disease	0.000102	0.000472	CbGpPWpGaD
Fulvestrant—CYP3A4—Metapathway biotransformation—CYP1A1—chronic obstructive pulmonary disease	0.000101	0.000466	CbGpPWpGaD
Fulvestrant—ESR1—Generic Transcription Pathway—SERPINE1—chronic obstructive pulmonary disease	9.79e-05	0.000451	CbGpPWpGaD
Fulvestrant—ESR1—Gene Expression—HDAC2—chronic obstructive pulmonary disease	9.63e-05	0.000444	CbGpPWpGaD
Fulvestrant—ESR2—Gene Expression—SERPINE1—chronic obstructive pulmonary disease	9.35e-05	0.000431	CbGpPWpGaD
Fulvestrant—ESR1—Signaling Pathways—CXCR2—chronic obstructive pulmonary disease	8.57e-05	0.000395	CbGpPWpGaD
Fulvestrant—NR1H4—Metabolism—ALB—chronic obstructive pulmonary disease	8.33e-05	0.000384	CbGpPWpGaD
Fulvestrant—CYP3A4—Metabolism—APIP—chronic obstructive pulmonary disease	8.25e-05	0.00038	CbGpPWpGaD
Fulvestrant—NR1H4—Metabolism—NOS3—chronic obstructive pulmonary disease	7.97e-05	0.000367	CbGpPWpGaD
Fulvestrant—ESR1—Signaling Pathways—HDAC2—chronic obstructive pulmonary disease	6.26e-05	0.000289	CbGpPWpGaD
Fulvestrant—ESR1—Signaling Pathways—KL—chronic obstructive pulmonary disease	5.82e-05	0.000268	CbGpPWpGaD
Fulvestrant—CYP3A4—Metabolism—RAPGEF3—chronic obstructive pulmonary disease	5.47e-05	0.000252	CbGpPWpGaD
Fulvestrant—ESR1—Signaling Pathways—ADRB2—chronic obstructive pulmonary disease	5.37e-05	0.000248	CbGpPWpGaD
Fulvestrant—CYP3A4—Metabolism—GC—chronic obstructive pulmonary disease	5.32e-05	0.000245	CbGpPWpGaD
Fulvestrant—CYP3A4—Metabolism—ALDH7A1—chronic obstructive pulmonary disease	4.94e-05	0.000228	CbGpPWpGaD
Fulvestrant—ESR1—Signaling Pathways—EDN1—chronic obstructive pulmonary disease	4.8e-05	0.000221	CbGpPWpGaD
Fulvestrant—ESR1—Gene Expression—SERPINE1—chronic obstructive pulmonary disease	4.71e-05	0.000217	CbGpPWpGaD
Fulvestrant—ESR1—Signaling Pathways—ERBB3—chronic obstructive pulmonary disease	4.37e-05	0.000201	CbGpPWpGaD
Fulvestrant—ESR1—Signaling Pathways—HTR2A—chronic obstructive pulmonary disease	4.2e-05	0.000194	CbGpPWpGaD
Fulvestrant—ESR1—Signaling Pathways—LEP—chronic obstructive pulmonary disease	3.91e-05	0.00018	CbGpPWpGaD
Fulvestrant—ESR1—Signaling Pathways—SERPINE1—chronic obstructive pulmonary disease	3.07e-05	0.000141	CbGpPWpGaD
Fulvestrant—ESR1—Signaling Pathways—NOS3—chronic obstructive pulmonary disease	2.93e-05	0.000135	CbGpPWpGaD
Fulvestrant—CYP3A4—Metabolism—GSTT1—chronic obstructive pulmonary disease	2.91e-05	0.000134	CbGpPWpGaD
Fulvestrant—CYP3A4—Metabolism—GCLC—chronic obstructive pulmonary disease	2.87e-05	0.000132	CbGpPWpGaD
Fulvestrant—CYP3A4—Metabolism—CTGF—chronic obstructive pulmonary disease	2.62e-05	0.000121	CbGpPWpGaD
Fulvestrant—ESR1—Signaling Pathways—CXCL8—chronic obstructive pulmonary disease	2.6e-05	0.00012	CbGpPWpGaD
Fulvestrant—CYP3A4—Metabolism—CYP1A2—chronic obstructive pulmonary disease	2.41e-05	0.000111	CbGpPWpGaD
Fulvestrant—ESR1—Signaling Pathways—MMP9—chronic obstructive pulmonary disease	2.35e-05	0.000108	CbGpPWpGaD
Fulvestrant—ESR1—Signaling Pathways—VEGFA—chronic obstructive pulmonary disease	2.11e-05	9.71e-05	CbGpPWpGaD
Fulvestrant—CYP3A4—Metabolism—GSTP1—chronic obstructive pulmonary disease	2.01e-05	9.28e-05	CbGpPWpGaD
Fulvestrant—CYP3A4—Metabolism—HMOX1—chronic obstructive pulmonary disease	1.99e-05	9.15e-05	CbGpPWpGaD
Fulvestrant—ESR1—Signaling Pathways—TGFB1—chronic obstructive pulmonary disease	1.93e-05	8.91e-05	CbGpPWpGaD
Fulvestrant—ESR1—Signaling Pathways—EGFR—chronic obstructive pulmonary disease	1.9e-05	8.74e-05	CbGpPWpGaD
Fulvestrant—CYP3A4—Metabolism—GSTM1—chronic obstructive pulmonary disease	1.85e-05	8.52e-05	CbGpPWpGaD
Fulvestrant—CYP3A4—Metabolism—CYP1A1—chronic obstructive pulmonary disease	1.75e-05	8.08e-05	CbGpPWpGaD
Fulvestrant—ESR1—Signaling Pathways—TP53—chronic obstructive pulmonary disease	1.59e-05	7.34e-05	CbGpPWpGaD
Fulvestrant—ESR1—Signaling Pathways—IL6—chronic obstructive pulmonary disease	1.46e-05	6.72e-05	CbGpPWpGaD
Fulvestrant—CYP3A4—Metabolism—ALB—chronic obstructive pulmonary disease	1.19e-05	5.49e-05	CbGpPWpGaD
Fulvestrant—CYP3A4—Metabolism—NOS3—chronic obstructive pulmonary disease	1.14e-05	5.25e-05	CbGpPWpGaD
